Carregant...
Antithyroid drugs in Graves’ disease: Are we stretching it too far?
INTRODUCTION: Early and durable achievement of euthyroid or hypothyroid status with low likelihood of relapse is the key to effective treatment of Graves’ disease (GD). Although antithyroid drugs (ATDs) are commonly used first-line agents, likelihood of remission remains highest with radioactive iod...
Guardat en:
| Publicat a: | Indian J Endocrinol Metab |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications & Media Pvt Ltd
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5040037/ https://ncbi.nlm.nih.gov/pubmed/27730067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.190525 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|